Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Effect of Covid-19 Vaccination on Management of Chronic Migraine With Botulinum Toxin: A Case Series Publisher



Fetratjoo DH1 ; Jafari E2 ; Togha M2
Authors

Source: Archives of Clinical Infectious Diseases Published:2023


Abstract

Introduction: Headache worsening has been previously reported following the coronavirus disease 2019 (COVID-19) vaccination. However, COVID vaccination’s influence on managing chronic migraine (CM) with botulinum toxin is yet to be studied. Case Presentation: In this case series, we present five cases of CM, who had responded to abobotulinum toxin type A (BTX-A), but their number of headache days increased after COVID vaccination. Conclusions: In the case of vaccination with COVID vaccines, during the first month of administering botulinum toxin for the management of CM, there might be a decrease in the efficacy of botulinum toxin, which should be explained to the patients. The authors suggest that physicians postpone the administration of BTX-A for chronic migraine management to a later time at their discretion. © 2023, Author(s).
Related Docs
View other Related Docs
1. Characteristics of Headaches Attributed to Sars-Cov-2 Vaccination and Factors Associated With Its Frequency and Prolongation: A Cross-Sectional Cohort Study, Frontiers in Neurology (2023)
2. Long-Term Treatment of Chronic Migraine With Onabotulinumtoxina: Efficacy, Quality of Life and Tolerability in a Real-Life Setting, Journal of Neural Transmission (2016)
3. A Randomized, Double-Blind Clinical Trial to Evaluate the Non-Inferiority of the Efficacy and Safety of Dyston to Dysport for Preventive Treatment of Chronic Migraine, Neurology and Clinical Neuroscience (2025)
Experts (# of related papers)
View all Related Experts
Mansoureh Togha (8)
Mohammad Ali Sahraian (2)
Other Related Docs
4. Migraine, Headache and Migraine in Practice (2022)
5. Headache Following Vaccination Against Covid-19 Among Healthcare Workers With a History of Covid-19 Infection: A Cross-Sectional Study in Iran With a Meta-Analytic Review of the Literature, Head and Face Medicine (2023)
6. International Headache Society Global Practice Recommendations for the Acute Pharmacological Treatment of Migraine, Cephalalgia (2024)
7. Safety and Adverse Events Related to Inactivated Covid-19 Vaccines and Novavax; a Systematic Review, Archives of Academic Emergency Medicine (2022)
8. Short-Term Side Effects of Covid-19 Vaccines Among Healthcare Workers: A Multicenter Study in Iran, Scientific Reports (2024)
9. Prevalence of Headaches in Healthcare Workers While Using Personal Protective Equipment During the Covid-19 Pandemic: A Systematic Review and Meta-Analysis, BMJ Open (2024)
10. A Review of the Potential Neurological Adverse Events of Covid-19 Vaccines, Acta Neurologica Belgica (2023)
11. The Perspective of Iranian Patients With Multiple Sclerosis on the Third Dose of Covid-19 Vaccine, Current Journal of Neurology (2022)
12. The Effects of a Multispecies Probiotic Supplement on Inflammatory Markers and Episodic and Chronic Migraine Characteristics: A Randomized Double-Blind Controlled Trial, Cephalalgia (2019)
13. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study, Headache (2016)
14. The Effectiveness of Botulinum Toxin for Temporomandibular Disorders: A Systematic Review and Meta-Analysis, PLoS ONE (2024)
15. The Prevalence of Migraine in Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2020)
16. Non-Migraine Head Pain and Botulinum Toxin, Toxins (2024)
17. Migraine Management: Non-Pharmacological Points for Patients and Health Care Professionals, Open Medicine (Poland) (2022)
18. Preventive Effect of Greater Occipital Nerve Block on Patients With Episodic Migraine: A Randomized Double‐Blind Placebo‐Controlled Clinical Trial, Cephalalgia (2022)
19. A Review on Headaches Due to Covid-19 Infection, Frontiers in Neurology (2022)
20. The Efficacy of Intradermal Injection of Botulinum Toxin Type-A on Painful Diabetic Neuropathy: A Systematic Review, Anesthesiology and Pain Medicine (2023)